• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

男性关于BRCA1/2预测性检测的决策:家庭的作用。

Men's decision-making about predictive BRCA1/2 testing: the role of family.

作者信息

Hallowell N, Ardern-Jones A, Eeles R, Foster C, Lucassen A, Moynihan C, Watson M

机构信息

Public Health Sciences, The Medical School, University of Edinburgh, United Kingdom.

出版信息

J Genet Couns. 2005 Jun;14(3):207-17. doi: 10.1007/s10897-005-0384-3.

DOI:10.1007/s10897-005-0384-3
PMID:15959652
Abstract

Men who have a family history of breast and/or ovarian cancer may be offered a predictive genetic test to determine whether or not they carry the family specific BRCA1/2 mutation. Male carriers may be at increased risk of breast and prostate cancers. Relatively little is known about at-risk men's decision-making about BRCA1/2 testing. This qualitative study explores the influences on male patients' genetic test decisions. Twenty-nine in-depth interviews were undertaken with both carrier and noncarrier men and immediate family members (17 male patients, 8 female partners, and 4 adult children). These explored family members' experiences of cancer and genetic testing, decision-making about testing, family support, communication of test results within the family, risk perception and risk management. Implicit influences on men's testing decisions such as familial obligations are examined. The extent to which other family members--partners and adult children--were involved in testing decisions is also described. It is demonstrated that mothers of potential mutation carriers not only perceive themselves as having a right to be involved in making this decision, but also were perceived by their male partners as having a legitimate role to play in decision-making. There was evidence that (adult) children were excluded from the decision-making, and some expressed resentment about this. The implications of these findings for the practice of genetic counseling are discussed.

摘要

有乳腺癌和/或卵巢癌家族病史的男性可能会接受预测性基因检测,以确定他们是否携带家族特有的BRCA1/2突变。男性携带者患乳腺癌和前列腺癌的风险可能会增加。对于有风险的男性关于BRCA1/2检测的决策,我们了解得相对较少。这项定性研究探讨了对男性患者基因检测决策的影响因素。对携带者和非携带者男性及其直系家庭成员(17名男性患者、8名女性伴侣和4名成年子女)进行了29次深入访谈。这些访谈探讨了家庭成员的癌症及基因检测经历、检测决策过程、家庭支持、家庭内部检测结果的沟通、风险认知和风险管理。研究还考察了诸如家庭义务等对男性检测决策的潜在影响因素。此外,还描述了其他家庭成员——伴侣和成年子女——参与检测决策的程度。结果表明,潜在突变携带者的母亲不仅认为自己有权参与这一决策,而且她们的男性伴侣也认为她们在决策过程中应发挥合理作用。有证据表明(成年)子女被排除在决策之外,一些子女对此表示不满。本文讨论了这些研究结果对遗传咨询实践的启示。

相似文献

1
Men's decision-making about predictive BRCA1/2 testing: the role of family.男性关于BRCA1/2预测性检测的决策:家庭的作用。
J Genet Couns. 2005 Jun;14(3):207-17. doi: 10.1007/s10897-005-0384-3.
2
Guilt, blame and responsibility: men's understanding of their role in the transmission of BRCA1/2 mutations within their family.内疚、指责与责任:男性对自身在家族中BRCA1/2基因突变传递中所扮演角色的理解。
Sociol Health Illn. 2006 Nov;28(7):969-88. doi: 10.1111/j.1467-9566.2006.00515.x.
3
Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing.有遗传性乳腺癌/卵巢癌基因突变携带风险的男性:基因检测期间的态度和心理功能探索
Eur J Hum Genet. 2001 Jul;9(7):492-500. doi: 10.1038/sj.ejhg.5200668.
4
Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer.胚胎植入前基因诊断和产前诊断的决策:对遗传性乳腺癌和卵巢癌夫妇的一项挑战。
Hum Reprod. 2014 May;29(5):1103-12. doi: 10.1093/humrep/deu034. Epub 2014 Mar 6.
5
Communication about genetic testing in families of male BRCA1/2 carriers and non-carriers: patterns, priorities and problems.男性BRCA1/2基因携带者和非携带者家庭中基因检测的沟通:模式、重点与问题
Clin Genet. 2005 Jun;67(6):492-502. doi: 10.1111/j.1399-0004.2005.00443.x.
6
Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.关于采用预测试教育方法以增强BRCA1基因检测知情决策的对照试验。
J Natl Cancer Inst. 1997 Jan 15;89(2):148-57. doi: 10.1093/jnci/89.2.148.
7
Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.BRCA1和BRCA2基因突变检测结果呈阳性后的心理社会问题:焦点小组和需求评估调查的结果
CMAJ. 2001 Apr 3;164(7):1005-9.
8
Information needs of mothers regarding communicating BRCA1/2 cancer genetic test results to their children.母亲在向子女传达BRCA1/2癌症基因检测结果方面的信息需求。
Genet Test. 2007 Fall;11(3):249-55. doi: 10.1089/gte.2006.0534.
9
Men's and Women's Approaches to Disclosure About BRCA-Related Cancer Risks and Family Planning Decision-Making.男性和女性对 BRCA 相关癌症风险和生育计划决策的披露方式。
Qual Health Res. 2018 Dec;28(14):2155-2168. doi: 10.1177/1049732318788377. Epub 2018 Jul 27.
10
BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.遗传性乳腺癌-卵巢癌家族中的BRCA1检测。一项关于患者决策及结果的前瞻性研究。
JAMA. 1996 Jun 26;275(24):1885-92.

引用本文的文献

1
Can Family Motivation Enhance Men's Uptake of Cascade Screening for Familial Mutations?家庭激励能否提高男性对家族性突变级联筛查的接受度?
Am J Mens Health. 2025 Jul-Aug;19(4):15579883251343962. doi: 10.1177/15579883251343962. Epub 2025 Aug 7.
2
A Multi-Level Analysis of Barriers and Promoting Factors to Cascade Screening Uptake Among Male Relatives of BRCA1/2 Carriers: A Qualitative Study.BRCA1/2基因携带者男性亲属级联筛查接受障碍与促进因素的多层次分析:一项定性研究
Psychooncology. 2025 May;34(5):e70160. doi: 10.1002/pon.70160.
3
Community concerns about genetic discrimination in life insurance persist in Australia: A survey of consumers offered genetic testing.

本文引用的文献

1
Factors Influencing Men's Interest in Gene Testing for Prostate Cancer Susceptibility.影响男性对前列腺癌易感性基因检测兴趣的因素。
J Genet Couns. 2002 Oct;11(5):383-98. doi: 10.1023/A:1016889614588.
2
Genetic testing for breast and ovarian cancer susceptibility: a family experience.乳腺癌和卵巢癌易感性的基因检测:一段家族经历
J Midwifery Womens Health. 2004 May-Jun;49(3):210-9. doi: 10.1016/j.jmwh.2004.01.021.
3
Uptake of BRCA1 genetic testing in adult sisters and daughters of known mutation carriers in Norway.挪威已知BRCA1基因突变携带者的成年姐妹和女儿进行BRCA1基因检测的情况。
澳大利亚的消费者在提供基因检测后,对寿险中的基因歧视仍存在担忧:一项消费者调查。
Eur J Hum Genet. 2024 Mar;32(3):286-294. doi: 10.1038/s41431-023-01373-1. Epub 2023 May 11.
4
Patient perspectives on risk-reducing salpingectomy with delayed oophorectomy for ovarian cancer risk-reduction: A systematic review of the literature.患者对降低卵巢癌风险的预防性输卵管切除术联合延迟卵巢切除术的看法:文献系统评价。
Gynecol Oncol. 2023 Jun;173:106-113. doi: 10.1016/j.ygyno.2023.04.006. Epub 2023 Apr 26.
5
Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-Analysis.遗传性癌症综合征的级联检测:我们是否应该转向直系亲属接触?系统评价和荟萃分析。
J Clin Oncol. 2022 Dec 10;40(35):4129-4143. doi: 10.1200/JCO.22.00303. Epub 2022 Aug 12.
6
Psychological Determinants of Men's Adherence to Cascade Screening for .心理因素对男性参与级联筛查的影响。
Curr Oncol. 2022 Apr 2;29(4):2490-2503. doi: 10.3390/curroncol29040203.
7
A randomized controlled trial comparing self-referred message to family-referred message promoting men's adherence to evidence-based guidelines on BRCA1/2 germline genetic testing: A registered study protocol.一项比较自我推荐信息与家庭推荐信息促进男性遵循 BRCA1/2 种系基因突变检测循证指南的依从性的随机对照试验:一项注册研究方案。
PLoS One. 2022 Apr 8;17(4):e0266327. doi: 10.1371/journal.pone.0266327. eCollection 2022.
8
Achieving universal genetic assessment for women with ovarian cancer: Are we there yet? A systematic review and meta-analysis.实现卵巢癌女性的普遍基因评估:我们做到了吗?系统评价和荟萃分析。
Gynecol Oncol. 2021 Aug;162(2):506-516. doi: 10.1016/j.ygyno.2021.05.011. Epub 2021 May 19.
9
Study protocol: the Australian genetics and life insurance moratorium-monitoring the effectiveness and response (A-GLIMMER) project.研究方案:澳大利亚遗传学与寿险暂缓—监测效果与反应(A-GLIMMER)项目。
BMC Med Ethics. 2021 May 21;22(1):63. doi: 10.1186/s12910-021-00634-2.
10
Decision-Making Preferences About Secondary Germline Findings That Arise From Tumor Genomic Profiling Among Patients With Advanced Cancers.晚期癌症患者中肿瘤基因组分析产生的二级胚系发现的决策偏好
JCO Precis Oncol. 2017;1. doi: 10.1200/PO.17.00182. Epub 2017 Dec 21.
J Genet Couns. 2003 Oct;12(5):405-17. doi: 10.1023/a:1025864703405.
4
The ethical management of genetic testing.
Eur J Cancer. 2003 Jul;39(10):1339-40. doi: 10.1016/s0959-8049(03)00274-0.
5
Balancing autonomy and responsibility: the ethics of generating and disclosing genetic information.平衡自主性与责任:生成和披露基因信息的伦理问题。
J Med Ethics. 2003 Apr;29(2):74-9; discussion 80-3. doi: 10.1136/jme.29.2.74.
6
Predictive testing for BRCA1 and 2 mutations: a male contribution.
Ann Oncol. 2003 Apr;14(4):549-53. doi: 10.1093/annonc/mdg164.
7
Motivations and concerns of women considering genetic testing for breast cancer: a comparison between affected and at-risk probands.考虑进行乳腺癌基因检测的女性的动机和担忧:患病先证者与高危先证者的比较
Genet Test. 2002 Fall;6(3):203-5. doi: 10.1089/109065702761403360.
8
Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients.癌症患者在进行遗传性乳腺癌和卵巢癌基因检测背景下与远近亲属的沟通。
Am J Med Genet A. 2003 Jan 1;116A(1):11-9. doi: 10.1002/ajmg.a.10868.
9
Genetic testing for women previously diagnosed with breast/ovarian cancer: examining the impact of BRCA1 and BRCA2 mutation searching.对先前被诊断患有乳腺癌/卵巢癌的女性进行基因检测:探究BRCA1和BRCA2基因突变检测的影响。
Genet Test. 2002 Summer;6(2):79-87. doi: 10.1089/10906570260199320.
10
Predictive testing for BRCA1/2: attributes, risk perception and management in a multi-centre clinical cohort.BRCA1/2基因的预测性检测:多中心临床队列中的特征、风险认知与管理
Br J Cancer. 2002 Apr 22;86(8):1209-16. doi: 10.1038/sj.bjc.6600253.